Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Scientex Berhad Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
Scientex Berhad yıllık ortalama 6.5% oranında kazançlarını artırırken, Chemicals sektöründe kazançlar growing at 6.5% annual. Gelirler growing yılda ortalama 5.8% oranında artmaktadır. Scientex Berhad'in özkaynak karlılığı 14.2% ve net marjı 12.2%'dir.
Anahtar bilgiler
6.5%
Kazanç büyüme oranı
6.3%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 8.9% |
| Gelir büyüme oranı | 5.8% |
| Özkaynak getirisi | 14.2% |
| Net Marj | 12.2% |
| Son Kazanç Güncellemesi | 31 Jul 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06
Sep 30
Analysts Are Updating Their Scientex Berhad (KLSE:SCIENTX) Estimates After Its Annual Results
Sep 26Scientex Berhad (KLSE:SCIENTX) Is Looking To Continue Growing Its Returns On Capital
Sep 09Scientex Berhad (KLSE:SCIENTX) Ticks All The Boxes When It Comes To Earnings Growth
Aug 06Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts Think
Jun 25Scientex Berhad (KLSE:SCIENTX) Is Increasing Its Dividend To MYR0.06
Jun 24Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen Next
Mar 28Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of Investors
Mar 27An Intrinsic Calculation For Scientex Berhad (KLSE:SCIENTX) Suggests It's 30% Undervalued
Sep 23Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.05
Sep 22Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Larger Dividend Than Last Year
Jun 26Estimating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)
May 11Scientex Berhad (KLSE:SCIENTX) May Have Issues Allocating Its Capital
Jan 27Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.05
Dec 09Scientex Berhad (KLSE:SCIENTX) Has Affirmed Its Dividend Of MYR0.05
Oct 02Scientex Berhad (KLSE:SCIENTX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Sep 23Here's Why Scientex Berhad (KLSE:SCIENTX) Can Manage Its Debt Responsibly
Sep 08Here's What's Concerning About Scientex Berhad's (KLSE:SCIENTX) Returns On Capital
Jul 13Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock
Apr 28Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 46% Undervaluation?
Mar 09These 4 Measures Indicate That Scientex Berhad (KLSE:SCIENTX) Is Using Debt Reasonably Well
Dec 09Calculating The Intrinsic Value Of Scientex Berhad (KLSE:SCIENTX)
Oct 21Return Trends At Scientex Berhad (KLSE:SCIENTX) Aren't Appealing
Sep 24I Built A List Of Growing Companies And Scientex Berhad (KLSE:SCIENTX) Made The Cut
Aug 21Does Scientex Berhad (KLSE:SCIENTX) Have A Healthy Balance Sheet?
Jun 08Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 28% Undervaluation?
May 26Scientex Berhad (KLSE:SCIENTX) Has Some Way To Go To Become A Multi-Bagger
May 11Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Mar 07Scientex Berhad's (KLSE:SCIENTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Should We Be Excited About The Trends Of Returns At Scientex Berhad (KLSE:SCIENTX)?
Feb 09Are Investors Undervaluing Scientex Berhad (KLSE:SCIENTX) By 25%?
Jan 27
Here's What We Learned About The CEO Pay At Scientex Berhad (KLSE:SCIENTX)
Jan 15Scientex Berhad (KLSE:SCIENTX) Passed Our Checks, And It's About To Pay A RM0.13 Dividend
Dec 30Here's Why We Think Scientex Berhad (KLSE:SCIENTX) Is Well Worth Watching
Dec 29Scientex Berhad (KLSE:SCIENTX) Has Gifted Shareholders With A Fantastic 186% Total Return On Their Investment
Dec 18What Type Of Shareholders Own The Most Number of Scientex Berhad (KLSE:SCIENTX) Shares?
Dec 06Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Nov 24Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Scientex Berhad nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Jul 24 | 4,476 | 545 | 0 | 0 |
| 30 Apr 24 | 4,379 | 524 | 288 | 0 |
| 31 Jan 24 | 4,268 | 504 | 288 | 0 |
| 31 Oct 23 | 4,154 | 469 | 288 | 0 |
| 31 Jul 23 | 4,077 | 438 | 288 | 0 |
| 30 Apr 23 | 4,117 | 448 | 286 | 0 |
| 31 Jan 23 | 4,113 | 427 | 286 | 0 |
| 31 Oct 22 | 4,087 | 414 | 286 | 0 |
| 31 Jul 22 | 3,985 | 410 | 286 | 0 |
| 30 Apr 22 | 3,844 | 428 | 258 | 0 |
| 31 Jan 22 | 3,827 | 449 | 258 | 0 |
| 31 Oct 21 | 3,782 | 468 | 258 | 0 |
| 31 Jul 21 | 3,656 | 457 | 258 | 0 |
| 30 Apr 21 | 3,640 | 457 | 236 | 0 |
| 31 Jan 21 | 3,436 | 416 | 236 | 0 |
| 31 Oct 20 | 3,443 | 402 | 236 | 0 |
| 31 Jul 20 | 3,519 | 390 | 236 | 0 |
| 30 Apr 20 | 3,503 | 381 | 213 | 0 |
| 31 Jan 20 | 3,559 | 385 | 213 | 0 |
| 31 Oct 19 | 3,411 | 361 | 213 | 0 |
| 31 Jul 19 | 3,247 | 334 | 213 | 0 |
| 30 Apr 19 | 3,029 | 283 | 167 | 0 |
| 31 Jan 19 | 2,797 | 272 | 167 | 0 |
| 31 Oct 18 | 2,661 | 266 | 167 | 0 |
| 31 Jul 18 | 2,603 | 285 | 167 | 0 |
| 30 Apr 18 | 2,528 | 274 | 164 | 0 |
| 31 Jan 18 | 2,568 | 279 | 164 | 0 |
| 31 Oct 17 | 2,523 | 276 | 164 | 0 |
| 31 Jul 17 | 2,403 | 256 | 164 | 0 |
| 30 Apr 17 | 2,318 | 238 | 163 | 0 |
| 31 Jan 17 | 2,226 | 233 | 163 | 0 |
| 31 Oct 16 | 2,185 | 232 | 163 | 0 |
| 31 Jul 16 | 2,201 | 241 | 163 | 0 |
| 30 Apr 16 | 2,092 | 236 | 122 | 0 |
| 31 Jan 16 | 2,004 | 217 | 122 | 0 |
| 31 Oct 15 | 1,921 | 189 | 122 | 0 |
| 31 Jul 15 | 1,802 | 158 | 122 | 0 |
| 30 Apr 15 | 1,765 | 158 | 112 | 0 |
| 31 Jan 15 | 1,736 | 152 | 112 | 0 |
| 31 Oct 14 | 1,657 | 149 | 112 | 0 |
| 31 Jul 14 | 1,590 | 148 | 112 | 0 |
| 30 Apr 14 | 1,546 | 130 | 96 | 0 |
| 31 Jan 14 | 1,465 | 123 | 96 | 0 |
| 31 Oct 13 | 1,352 | 115 | 96 | 0 |
Kaliteli Kazançlar: SCIENTX yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: SCIENTX 'nin mevcut net kar marjları (12.2%) geçen yılın (10.7%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: SCIENTX şirketinin kazancı son 5 yılda yılda 6.5% oranında arttı.
Büyüme Hızlandırma: SCIENTX 'un son bir yıldaki kazanç büyümesi ( 24.4% ) 5 yıllık ortalamasını (yıllık 6.5% ) aşıyor.
Kazançlar vs. Sektör: SCIENTX geçen yılki kazanç büyümesi ( 24.4% ) Chemicals sektörünün 24.9% performansını geride bırakmadı.
Özkaynak Getirisi
Yüksek ROE: SCIENTX 'nin Özsermaye Getirisi ( 14.2% ) düşük olarak değerlendiriliyor.